Novus Biologicals™ CCL11/Eotaxin Antibody Blocking Peptide

Description

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

A blocking peptide containing 15 amino acids near the carboxy terminus of human Eotaxin. Source: Synthetic (Accession #: CAB07027) The CCL11/Eotaxin Blocking Peptide has been validated for the following applications: Antibody Competition.

Specifications

• Gene ID (Entrez): 6356
• Species: Human
• Content And Storage: Store at -20 C. Avoid freeze-thaw cycles.
• Formulation: PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
• For Use With (Application): This Peptide is Useful as a Blocking Peptide for NBP1-77046. For Further Blocking Peptide Related Protocol, Click Here .
• Gene Alias: C-C motif chemokine 11, chemokine (C-C motif) ligand 11, Eosinophil chemotactic protein, eotaxin, eotaxin-1, MGC22554, SCYA11Small-inducible cytokine A11, small inducible cytokine subfamily A (Cys-Cys), member 11 (eotaxin)
• Gene Symbol: CCL11
• Product Type: CCL11/Eotaxin
• Quantity: 0.05 mg
• Regulatory Status: RUO - research use only
• Source: Synthetic
• Termination: 15 amino acids near the carboxy terminus of human Eotaxin